Cite
HARVARD Citation
Weinblatt, M. et al. (2013). Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial. Annals of the rheumatic diseases. 72 (3), pp. 381-389. [Online].